Literature DB >> 8513847

The influence of steady-state ciprofloxacin on the pharmacokinetics and pharmacodynamics of a single dose of diazepam in healthy volunteers.

F Kamali1, S H Thomas, C Edwards.   

Abstract

The effects of pretreatment with a seven day course of ciprofloxacin on pharmacokinetics and pharmacodynamics of an intravenous (5 mg) dose of diazepam were investigated in a group of 12 healthy volunteers in a double-blind placebo-controlled crossover study. Ciprofloxacin pretreatment significantly reduced diazepam CL (without ciprofloxacin: 19.5 ml.h-1 kg-1; with ciprofloxacin: 12.3 ml.h-1 kg-1). Diazepam t1/2 was also prolonged (without ciprofloxacin: 36.7 h; with ciprofloxacin: 71.1 h), but volume of distribution was unaltered (without ciprofloxacin: 1.1 l.kg-1; with ciprofloxacin: 1.1 l.kg-1). However, no significant changes were detected in psychometric tests of digit symbol substitution, tapping rate and short memory, as well as levels of concentration, vigilance and tension measured by visual analogue scales.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513847     DOI: 10.1007/BF00316474

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Effect of ciprofloxacin on the pharmacokinetics of antipyrine in healthy volunteers.

Authors:  K K Tan; M C Allwood; S Shawket
Journal:  J Clin Pharm Ther       Date:  1990-04       Impact factor: 2.512

2.  The adverse effects of fluoroquinolones.

Authors:  C R Smith
Journal:  J Antimicrob Chemother       Date:  1987-06       Impact factor: 5.790

3.  Pharmacology of the metabolites of chlordiazepoxide and diazepam.

Authors:  L O Randall; C L Scheckel; R F Banziger
Journal:  Curr Ther Res Clin Exp       Date:  1965-09

4.  Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.

Authors:  S Harder; U Fuhr; A H Staib; T Wolff
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

5.  Central nervous system toxicity of quinolones: human and animal findings.

Authors:  W Christ
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

Review 6.  Safety profile of the quinolones.

Authors:  R Stahlmann
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

7.  The influence of quinolone derivatives on theophylline clearance.

Authors:  W J Wijnands; T B Vree; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.

Authors:  S Segev; M Rehavi; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

10.  Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Authors:  A Tsuji; H Sato; Y Kume; I Tamai; E Okezaki; O Nagata; H Kato
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

View more
  5 in total

1.  Assessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.

Authors:  F Kamali; C H Ashton; V R Marsh; J Cox
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study.

Authors:  F Kamali
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 3.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

4.  Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.

Authors:  Yuanyuan Wang; Muh Akbar Bahar; Anouk M E Jansen; Janwillem W H Kocks; Jan-Willem C Alffenaar; Eelko Hak; Bob Wilffert; Sander D Borgsteede
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

5.  A chitosan gold nanoparticles molecularly imprinted polymer based ciprofloxacin sensor.

Authors:  Sandeep G Surya; Shahjadi Khatoon; Abdellatif Ait Lahcen; An T H Nguyen; Boris B Dzantiev; Nazia Tarannum; Khaled N Salama
Journal:  RSC Adv       Date:  2020-03-31       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.